ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 088

Sun Protection Use in Patients Followed in a Pediatric Rheumatology Clinic in an Urban Setting

Tamara Tanner1, Gabriel Tarshish 2, Dawn Wahezi 3 and Tamar Rubinstein 4, 1Montefiore Medical Center, Bronx, 2Children's Hospital at Montefiore, New York, 3Children's Hospital at Montefiore, Bronx, 4Albert Einstein College of Medicine, White Plains

Meeting: 2020 Pediatric Rheumatology Symposium

Keywords: cutaneous lupus, Lupus, sun

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

The 2020 Pediatric Rheumatology Symposium, originally scheduled for April 29 – May 2, was postponed due to COVID-19; therefore, abstracts were not presented as scheduled.

Date: Friday, May 1, 2020

Title: Poster Session 2

Session Type: ACR Abstract Session

Session Time: 5:00PM-6:00PM

Background/Purpose: Exposure to sunlight has been implicated as a major contributing factor in the pathogenesis of systemic lupus erythematosus (SLE) and juvenile dermatomyositis (JDM). Despite this evidence, assuring adequate sunscreen use in the pediatric rheumatology patient population remains a challenge. Counseling surrounding adequate sun protection is part of routine clinical practice in pediatric clinics in the US based on American Academy of Pediatrics recommendations. However, studies have shown that prevalence of sunscreen use in children and adolescents is suboptimal with reports of adequate use varying between 13-34%. Adherence also varies based on age, gender and ethnicity. Evidence is lacking regarding sun protection habits among pediatric rheumatology patients and potential barriers to its use. This information is crucial to improve counseling practices for this ubiquitous risk factor. This study aims to investigate sun protection practices in patients being followed in pediatric rheumatology clinic and investigate practice differences in youth with photosensitive versus non photosensitive rheumatologic conditions, as well as risk factors for inadequate sun protection.

Methods: We developed a survey assessing sun protection practices and barriers to adequate usage. The survey was comprised of up to 30 questions and was offered to patients 2-21 years old being seen for routine follow up visits in the pediatric rheumatology clinic at the Children’s Hospital at Montefiore in the Bronx, NY. Patients surveyed had a variety of photosensitive and non-photosensitive conditions, including SLE, JDM, cutaneous lupus erythematosus (CLE), Juvenile Idiopathic Arthritis, and scleroderma. The survey was collected electronically via the Einstein-Montefiore REDCap (Research Electronic Data Capture), a secure web-based application for data collection.

Results: We have enrolled 204 patients to date. Of these, 74 (37%) were diagnosed with a photosensitive skin condition including SLE, JDM or CLE. The median age at enrollment was 15 years old (IQR 12, 18) with the majority of female gender (75%). Race and ethnicity were self-reported with 58% of patients identifying as Hispanic ethnicity; for race, 45% identified as Black, 21% white, 35% other (includes patients who declined to answer). Most patients identified as having darker skin: 52 patients (26%) reported type I or II skin phototype (“burn easily”), 69 patients (35%) type III (“burn moderately”) and 79 patients (40%) types IV-VI (“never burn”).

Among the entire group, 36% reported using sunscreen “daily or most days” which was deemed as appropriate use. Most patients (64%) agreed or strongly agreed sun protection is important. A large majority (69%) of our patients reported spending 2 or more hours outdoors daily in the past month.

Factors associated with adequate sunscreen use were having a photosensitive skin condition, recall of counseling on sunscreen use at initial diagnosis and spending >= 2 hours outdoors daily (Table 1).

Conclusion: This study identifies gaps in sun protection use in a large proportion of patients with rheumatologic disease, including those with photosensitive skin diseases.

Factors associated with adequate sunscreen use in a cohort of pediatric rheumatology patients


Disclosure: T. Tanner, None; G. Tarshish, None; D. Wahezi, None; T. Rubinstein, None.

To cite this abstract in AMA style:

Tanner T, Tarshish G, Wahezi D, Rubinstein T. Sun Protection Use in Patients Followed in a Pediatric Rheumatology Clinic in an Urban Setting [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 4). https://acrabstracts.org/abstract/sun-protection-use-in-patients-followed-in-a-pediatric-rheumatology-clinic-in-an-urban-setting/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2020 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/sun-protection-use-in-patients-followed-in-a-pediatric-rheumatology-clinic-in-an-urban-setting/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology